Internal Medicine, Nephrology · Minneapolis, MN
NPI
1235424276
Since 2011
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
500 Harvard St SE
Minneapolis, MN, 55455
Phone (612) 626-3366
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,062 services
Medicare patients, 2024
272
Average age 58
Drug cost, 2024
$184K
2,452 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rasha S El Rifai was code 99233 (hospital e&m - subsequent), 400 times for 95 patients. In total Rasha S El Rifai billed 1,062 services in 14 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 400 | 95 | $88.43 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 210 | 140 | $11.75 | $2,468 |
| 99214 Office E&M - Established | Facility | 135 | 104 | $61.73 | $8,334 |
| 99215 Office E&M - Established | Facility | 96 | 79 | $91.66 | $8,799 |
| 99223 Hospital E&M - Initial | Facility | 88 | 76 | $127.98 | $11K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 38 | 37 | $11.55 | $439 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 31 | 19 | $23.39 | $725 |
| 99214 Office E&M - Established | Office | 25 | 25 | $65.14 | $1,629 |
| 99215 Office E&M - Established | Office | 20 | 20 | $96.56 | $1,931 |
By year: 2022 $64K for 759 services; 2023 $66K for 770 services; 2024 $72K for 1,062 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rasha S El Rifai prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 504 prescriptions and refills. In total Rasha S El Rifai wrote 2,452 Medicare prescriptions that cost $184K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 504 | 718 | 107 | $4,526 |
| Tacrolimus Generic | 179 | 352 | 39 | $28K |
| Carvedilol Generic | 176 | 300 | 47 | $1,309 |
| Prednisone Generic | 171 | 308 | 46 | $1,124 |
| Atorvastatin Calcium Generic | 168 | 287 | 49 | $1,314 |
| Amlodipine Besylate Generic | 136 | 283 | 45 | $1,197 |
| Mycophenolate Mofetil Generic | 89 | 200 | 24 | $10K |
| Cinacalcet Hcl Generic | 82 | 123 | 23 | $16K |
| Famotidine Generic | 60 | 123 | 22 | $524 |
| Dapsone Generic | 59 | 94 | 16 | $4,182 |
| Losartan Potassium Generic | 54 | 125 | 21 | $803 |
| Valganciclovir Hcl Generic | 49 | 63 | 25 | $13K |
| Cyclosporine Modified Cyclosporine, Modified | 45 | 67 | Under 11 | $6,199 |
| Mycophenolic Acid Mycophenolate Sodium | 45 | 81 | 11 | $8,211 |
| Nifedipine Er Nifedipine | 44 | 64 | Under 11 | $584 |
Brand drugs: 91 claims; generic drugs: 2,347 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Rasha S El Rifai were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.